Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,187 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: Dayton OH, St. Louis MO, Alpharetta GA, Memphis TN,
Sponsor: Neuralstem Inc.

Sex: All

Age: 18 - 61

Code: NCT02724735

Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Dayton OH, Indianapolis IN, Ann Arbor MI,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase 3, Recruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

for
Overweight, Obesity
Location: Dayton OH, Columbus OH, Indianapolis IN, Baltimore MD,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 8 - 18

Code: NCT07253285

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Dayton OH, Springboro OH, Columbus OH, Lexington KY,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Dayton OH, Springboro OH, Columbus OH, Lexington KY,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Cincinnati OH, Chicago IL, Lawrenceville GA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07571005

Phase 3, Recruiting
Active & Responsive

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Cincinnati OH, Chicago IL, Lawrenceville GA, Atlanta GA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07571109

Phase 3, Recruiting
Active & Responsive

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Dayton OH, Chicago IL, Statesville NC, Greensboro NC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 70+

Code: NCT07415954

Phase 2, Recruiting
Active & Responsive

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for
Obesity, Heart Failure
Location: Dayton OH, Vandalia OH, Marion OH, Indianapolis IN,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07567001

Phase 3, Recruiting
FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for
Bipolar I Disorder, Bipolar II Disorder
Location: Cincinnati OH, Columbus OH, Chicago IL, Warrenville IL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase 2, Recruiting
FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
Location: Cincinnati OH, Columbus OH, Avon Lake OH, Chicago IL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase 2, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Florence KY, Indianapolis IN, Canton OH,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting

Healthy Heart Score Intervention In the Primary Care Setting

for
Cardiovascular Diseases
Location: Dublin OH
Sponsor: Ohio University

Sex: All

Age: 18+

Code: NCT03482427

Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Dublin OH, Carmel IN, Chicago IL, Elmhurst IL,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Columbus OH, Dublin OH, Delaware OH, Westerville OH,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Columbus OH, Dublin OH, Delaware OH, Westerville OH,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Columbus OH, Dublin OH, Marion OH, Mansfield OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Edgewood KY, Fort Wayne IN, Zanesville OH, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Edgewood KY, Columbus OH, Huntington WV, Ypsilanti MI,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase 2, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: Edgewood KY, Hilliard OH, Indianapolis IN, Milwaukee WI,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting